Email Updates

You are here

HIV Vaccine

There is momentum and promise in the search for an HIV vaccine.

An effective preventive HIV vaccine would teach the body how to prevent HIV infection. Vaccines are the most powerful public health tools available—and an HIV vaccine would play a powerful role in ensuring the end to the AIDS epidemic.

While effective vaccines remain years away, there are more reasons for hope than ever before. Researchers are pursuing groundbreaking research with number of vaccine strategies, including broadly neutralizing antibodies that target a wide range of HIV strains. At the same time, there is also exciting work in efforts to understand if and how to cure HIV in people who are already infected. The timeline for this work is long and uncertain. Here, too, advocacy is needed to sustain momentum.

Today’s momentum depends on sustained funding. Policy makers and funders around the world must have the courage to sustain vital HIV vaccine research for years to come, and advocates must keep the pressure on them to maintain their commitments.

What We're Reading

In a world first for vaccines, researchers at France's Vaccine Research Institute have completed experiments that target essential cells for combating HIV/AIDS and stimulate dendritic cells, the so-called sentinels of our immune system. Clinical trials are set to begin within weeks.

February 26, 2021

Crises have a habit of accelerating history, including the pace of technological advancement. The COVID-19 pandemic is no exception. Vaccines were developed, safely but with unprecedented efficiency, less than a year after the WHO declared a global pandemic.

February 23, 2021
Vaccines Today

A phase 1 clinical trial testing a novel vaccine approach to prevent HIV has produced promising results, Scripps Research and IAVI announced Wednesday. The vaccine showed success in stimulating production of rare immune cells needed to start the process of generating antibodies against the fast-mutating virus. The targeted response was detected in 97 percent of participants who received the vaccine.

February 3, 2021
Times of San Diego

Scientists would likely look into the potential of mRNA technology as the search for an HIV vaccine continues. This technology has become a game-changer helping scientist’s find a vaccine against the coronavirus.

January 15, 2021
Africa News
Subscribe to RSS - HIV Vaccine